Simon H. Stertzer MD

Adult Congenital Heart Disease, Interventional Cardiology

Professor Emeritus Stanford University

Summary

Professor Emeritus at Stanford University. Career efforts dedicated to advancing cardiovascular intervention.

Primary research interests include advancements in coronary angioplasty, atherectomy, cardiac stents, drug delivery stents, cardiac transplant molecular diagnostics, drugs to treat vein grafts, and most recently, transendocardial stem cell implantation in ischemic heart failure.

Co-founded several interventional startups, including Arterial Vascular Engineering, Inc., acquired by Medtronic, Inc.; and BioCardia®, Inc., a biotechnology regenerative medicine company that develops innovative therapeutics for the treatment of cardiovascular disease.

NYU Grossman School of MedicineFellowship, Cardiovascular Disease, 1965 - 1967
NYU Grossman School of MedicineResidency, Internal Medicine, 1962 - 1965
University of California (San Francisco) School of MedicineInternship, Transitional Year, 1961 - 1962
New York University School of MedicineClass of 1961
Union CollegeAB, 1953 - 1957
University of Paris (Sorbonne)Certificat De Physiologie, 1955 - 1956

New York University Founders Day Award
Knight of the Knights of Malta
Knight Commander of the Knights of Malta
Guest Professor, Emory University School of Medicine, Department of Medicine
Elected Member of the Sociedad Argentina da Cardiologia
Title of “Dato” Conferred by the King of Malaysia
Guest Faculty, Cardiology Department, Hospital General Universitario Gregorio Marañón, Madrid Spain
Honorary Professor Instituto Nacional de Cardiologia, Ignacio Chavez, Mexico City, Mexico
Commemoration of the 20th Anniversary of the First Angioplasty performed in the United States and in recognition of two decades of outstanding leadership in research, teaching, and patient care Stanford University Medical Center
Simon H. Stertzer, M.D. Chair in Interventional Cardiology Stanford University
University Institute of Health Sciences of the H. A. Barcelo Foundation “Doctor Honoris Causa” Conferred by University Institute of Health Sciences of the H. A. Barcelo Foundation, Buenos Aires, Argentina.
Universidad del Salvador, Buenos Aires “Profesor Honorario” Conferred by the Universidad del Salvador, Buenos Aires, Republica Argentina.
Colegio Argentino De Cardioangiologos Intervencionistas, Buenos Aires “Miembro Titula Honorario” Conferred by Colegio Argentino De Cardioangiologos Intervencionistas, Buenos Aires, Republica Argentina.
Fellow (FACC) American College of Cardiology
Join now to see all

PubMed

Stanford Medicine Study Discovers What’s Behind Heart Cell Damage from ChemotherapyNovember 27th, 2024
How Space Became a Place for the Study of AgingSeptember 6th, 2024
38 Best Healthcare Startups to Watch in 2022October 27th, 2022
Join now to see all